Cost and Effectiveness of Therapy for Wet Age-Related Macular Degeneration in Routine Clinical Practice

Publisher： Karger

E-ISSN： 1423-0267|230|1|34-42

ISSN： 0030-3755

Source： Ophthalmologica, Vol.230, Iss.1, 2013-06, pp. : 34-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost of care for patients with age-related macular degeneration in Switzerland and cost-effectiveness of treatment with verteporfin therapy

By Greiner Roger-Axel  

Seminars in Ophthalmology, Vol. 16, Iss. 4, 2001-12 ,pp. : 218-222

Informa Healthcare

Access to resources Recommend Favorite

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: From clinical trials to clinical practice

By Sickenberg Michel  

Seminars in Ophthalmology, Vol. 16, Iss. 4, 2001-12 ,pp. : 207-212

Informa Healthcare

Access to resources Recommend Favorite

Intravitreal Ranibizumab in Daily Clinical Practice for Age-Related Macular Degeneration: Treatment of Exudative Age-Related Macular Degeneration in Real Life

By  

Ophthalmologica, Vol. 234, Iss. 1, 2015-06 ,pp. : 26-32

Karger

Access to resources Recommend Favorite

Aflibercept as First-Line Therapy in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Prospective Case Series Analysis in Real-Life Clinical Practice

By  

Ophthalmologica, Vol. 236, Iss. 1, 2016-06 ,pp. : 29-35

Karger

Access to resources Recommend Favorite

Quadruple Therapy Leads to a Sustained Improvement of Vision in Patients with Wet Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 226, Iss. 2, 2011-05 ,pp. : 45-50

Karger

Access to resources Recommend Favorite